Novo Nordisk posts results of Phase 3 liraglutide trial in children with obesity
Results for the 56-week, double-blind, randomized, placebo-controlled trial were first posted on ClinicalTrials.gov on November 16, 2026. The study enrolled 82 children aged 6 to below 12 years to evaluate the effect and safety of liraglutide 3.0 mg on weight management.
Primary source
ClinicalTrials.gov results record, November 16, 2026
SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity
Read the source: SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity clinicaltrials.gov
Machine-summarized from the source above; not independently reported. How we use automation